Blue Therapeutics Overview

  • Founded
  • 2014
  • Status
  • Private
  • Employees
  • 3
  • Latest Deal Type
  • Series A
  • Investors
  • 8

Blue Therapeutics General Information


Developer of an Investigational New Drug (IND)-stage drug discovery and development platform created to help in advancing transformative new medicines. The company's R2i technology delivers novel therapeutics that overcome the side effect profiles and limited efficacy of traditional pharmacological approaches by leveraging a new dimension of disease biology, thereby helping patients to get superior outcomes with the support of the receptor-interactomics approach of the company.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Drug Delivery
Primary Office
  • 203 Crescent Street
  • Suite 110
  • Waltham, MA 02453
  • United States

Blue Therapeutics Timeline

Financing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Blue Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC (Series A) 30-Apr-2021 Completed Pre-Clinical Trials
6. Grant 01-Jan-2020 00000 Completed Pre-Clinical Trials
5. Grant 15-Mar-2019 00.000 Completed Startup
4. Grant 01-Jan-2016 00000 Completed Startup
3. Accelerator/Incubator 20-May-2015 Completed Startup
2. Grant 30-Apr-2015 $5K Completed Startup
1. Accelerator/Incubator Completed Startup
To view Blue Therapeutics’s complete valuation and funding history, request access »

Blue Therapeutics Executive Team (6)

Name Title Board Seat Contact Info
Stefan Bluemmers MD President, Chief Executive Officer and Board Member
Ajay Yekkirala Ph.D Co-Founder, Board Member & Chief Scientific Officer
Harald Stock Ph.D Executive Chairman
You’re viewing 3 of 6 executive team members. Get the full list »

Blue Therapeutics Board Members (4)

Name Representing Role Since
Ajay Yekkirala Ph.D Blue Therapeutics Co-Founder, Board Member & Chief Scientific Officer 000 0000
Harald Stock Ph.D Self Executive Chairman 000 0000
You’re viewing 2 of 4 board members. Get the full list »

Blue Therapeutics Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Blue Therapeutics Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
MassVentures Venture Capital Minority 000 0000 000000 0
National Institute on Drug Abuse (NIDA) Other 000 0000 000000 0
National Institutes of Health Government 000 0000 000000 0
The Roddenberry Foundation Corporation 000 0000 000000 0
United States Department of Defense Government 000 0000 000000 0
You’re viewing 5 of 8 investors. Get the full list »